Differential diagnosis and management of acute profound thrombocytopenia by tirofiban : A case report
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Link
http://link.springer.com/content/pdf/10.1007/s11239-006-7789-1.pdf
Reference12 articles.
1. Boersma E, Harrington EA, Moliterno DJ, et al. (2002) Platelet glycoprotein IIb/IIIa inhibi-tors in acute coronary syndromes: a meta-analysis of all majr randomized trials. Lancet 359:189–198
2. Karvouni E, Katritsis DG, Ioannidis J (2003) Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. J Am Coll Cardiol 41:26–32
3. RESTORE Investigators (1997) Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 96:1445–1453
4. PRISM Study Investigators (1998) A comparision of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 338:1498–1505
5. PRISM-PLUS Study Investigators (1998) Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non Q-wave myocardial infarction. N Engl J Med 338:1488–1497
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tirofiban-induced thrombocytopenia;Annals of Medicine;2023-07-13
2. Use of Cangrelor as a Bridge to Left Ventricular Assist Device Implantation in a Patient with a Recent Drug‐Eluting Stent Who Developed Acute Tirofiban‐Related Thrombocytopenia;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2019-03-04
3. A Simple Clinical Pre-procedure Risk Model for Predicting Thrombocytopenia Associated With Periprocedural Use of Tirofiban in Patients Undergoing Percutaneous Coronary Intervention;Frontiers in Pharmacology;2018-12-10
4. Thrombopénie sévère et prolongée induite par un inhibiteur de la glycoprotéine IIb/IIIa;La Revue de Médecine Interne;2017-11
5. Tirofiban;Meyler's Side Effects of Drugs;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3